Showing results (11-20 of 261) with videos related to
Sort By:
Pageof 27
Cell Cycle (Georgetown, Tex.)|July 3, 2008
Conditional RNA interference in vivo to study mutant p53 oncogenic gain of function on tumor malignancyGianluca Bossi, Francesco Marampon, Revital Maor-Aloni, et al.Omics : a Journal of Integrative Biology|February 22, 2011
ChIP-on-chip analysis of in vivo mutant p53 binding to selected gene promotersStefania Dell'Orso, Giulia Fontemaggi, Perry Stambolsky, et al.Oncogene|August 29, 2003
Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutantsAmir Zalcenstein, Perry Stambolsky, Lilach Weisz, et al.Cell Death and Differentiation|October 15, 2016
TM7SF3, a novel p53-regulated homeostatic factor, attenuates cellular stress and the subsequent induction of the unfolded protein responseRoi Isaac, Ido Goldstein, Noa Furth, et al.Molecular Biosystems|December 22, 2009
Transcriptional control of the proliferation cluster by the tumor suppressor p53Ran Brosh, Varda RotterEuropean Journal of Cancer (Oxford, England : 1990)|September 25, 2009
p53: balancing tumour suppression and implications for the clinicYosef Buganim, Varda RotterTrends in Endocrinology and Metabolism: TEM|July 24, 2012
Regulation of lipid metabolism by p53 - fighting two villains with one swordIdo Goldstein, Varda RotterNature Reviews. Cancer|August 21, 2009
When mutants gain new powers: news from the mutant p53 fieldRan Brosh, Varda RotterCarcinogenesis|March 24, 2017
p53 and its mutants on the slippery road from stemness to carcinogenesisAlina Molchadsky, Varda RotterHuman Mutation|March 6, 2003
TP53 in hematological cancer: low incidence of mutations with significant clinical relevanceShoshana Peller, Varda RotterPageof 27